The future of cell therapy: challenges & solutions
One of the biggest hurdles in commercializing cell therapies is not the regulatory process, nor is it marketing a brand new, first-in-class product. Instead, many feel that the biggest challenge facing companies developing cell and gene therapies is proving to be the manufacturing process. Manufacturing CAR-T therapies presents multiple unique challenges. First, developing a personalized…
